The Falcoscan Intel Panel/QuantHealth · Healthcare
Live market data
Opportunity
84
Strong/ 100
Saturation
11
Open/ 100
Wrapper Risk
9
Open/ 100
Signal
Hot
Market trend
The Brief
What QuantHealth does
QuantHealth runs AI simulations that predict how patients will respond to therapies. Drug makers use it to test trial designs, forecast enrollment and optimize protocols before they commit patients or budget. CTech reports it has simulated more than 600 trials across 30 indications for 12 of the world's 20 largest pharma companies.
Builder’s Brief
QuantHealth is a healthcare tool on Falcoscan. AI simulation of clinical trials to predict patient responses before enrollment. Falcoscan rates QuantHealth with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. QuantHealth is founded in 2020, currently at Series_b stage. Pricing: Paid.
Market position · Healthcare
How QuantHealth compares in Healthcare
QuantHealth's opportunity score of 84 ranks #37 of 137 live Healthcare tools on Falcoscan, 2.2 points above the category average of 81.8. Its saturation score is 11/100, against a category average of 11. 75 of the 137 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.
QuantHealth compared with top-rated Healthcare tools
The top-rated live Healthcare tools on Falcoscan, other than QuantHealth, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.
Is QuantHealth still operating?
Yes. Falcoscan's operating checks list QuantHealth as active.
Where is QuantHealth based?
QuantHealth is headquartered in Tel Aviv, Israel.
Does QuantHealth have an API?
Yes. QuantHealth offers an API.
Who is QuantHealth for?
QuantHealth is built for pharmaceutical companies, biotech companies, and clinical development teams.